View for Long term investment : Not positional swing Good levels to accumulate if you are a long term view of 2 years or higher timeframe. The company caters to diverse end-user industries like Pharmaceuticals, Animal Health, Agrochemicals, Consumer Packaged Goods, Chemicals/Polymers. It has 360+ active customers with engagements with 8 out of the top 10 global...
The 10% rise in such scripts seems to excite a lot of retail participants. The chart illustrates how the script could be onboarding retailers into a sinking ship for now. It could reamin at 10 and below and you will lose many golden oppurtunities (oppurtunity cost) from other good scripts in market. However, Stocks are dynamic, so when one can enter this...
Its simple, as long as Zerodha the leading broker in India continue to open demats with CDSL this stock will out perform. This BO wallet is a proxy bet on the discount broker. Platform + High OPM and GM Expansion will lead to explosive run in this counter.
Lupin could break its ATH in next year. Target 1 is 1400. Has potential for 2x. View negated if US FDA, or other factors break the pattern. Lupin sees strong traction for its India business and expects growth to be in the high-teens in FY2022, which would be driven by strong growth in the base business, especially chronic therapies. The US business is expected to...
Add the stock if it retraces. SL 690 WCB Target 1000 Recommendation is to Hold as Insurance sector overall will gain from increased awareness and adoption post covid.
ITC - Everybodys favourite stock is looking set to launch. It looks like in a overrun bull market , there arent many stocks with resonable valuation and here is where ITC could be in radar of institutions and the buying may start. This is a thesis that could play out. No a recommedation, No entry. No of share holders is too high so price movement is very...
Morepen Laboratories is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products. Entry : 55- 57 SL : 50 Target1 : 72 Target2 : 100+ (After breaking out 72 )
Mastek is a provider of vertically-focused enterprise technology solutions. Having its presence in IT industry for almost 4 decades, Mastek Ltd has evolved from an IT solutions provider to Digital transformation partner. www.screener.in Entry - 2750-2950 ( If Price retraces and retests the breakout, but momemtum looking strong so price may not retrace and just...
Entry : 760-790 Target 1 : 960 Target 2 : Upto 1220 ( Trail the SL) SL : 695 WCB Strenght: www.screener.in Vaibhav Global Limited (VGL), through its distinctive business model, has created a niche for itself in the global retail space, especially in the jewellery, accessories and lifestyle product segments of two of the largest economies of the world...
BF Utilities Ltd. (BFUL) is a part of USD 2.4 billion Kalyani Group. BFUL earlier operated in two business segments – Infrastructure Business and Investment Business. BFUL has undergone business restructuring by way of a Composite Scheme of Arrangement. This is a bet on Renewables energy sector, stock will benifit from Govt pushes for wind energy creating a pentup demand.
Caplin Point Laboratories Ltd SMALL CAP Positonal Swing , Upside upto 40% Stop Loss 685
IT Stock is in consolidating in a flag and pole pattern Very good risk to reward ratio CMP 412 Target 580-600 SL - 400 WCB
6 year breakout Diageo seems be turning around the fortuens of united spirits after VijayMallyas turmoil. This liquor stock looks all set to conquer its all time highs and regain the valuaitons.
The sharp trended decline in this stock price (Rallis India Ltd) is in the process of reversing up in this week. The stock price has witnessed a sustainable upside bounce so far from near its support of up sloping trend line at Rs 274 levels. Hence, one may expect further upside to confirm a bottom reversal pattern in the stock price. The larger degree of higher...
India's Renewable Sector Outlook is bright. The only Solar Glass manufacturer in India, backed by good management. Company has doubled its capacity twice in last 4 years and still cannot meet the demand. One of the few profitable non China solar glass manufacturers in the world. Stock can break the ATH of 400 and move higher. Good support at 280-300. View...
Very long consolidation break and now the Break out from the previous ATH Fundamentally very sound company - It is like a FMCG of pharma Pirce closing above 20000 will fuel further rally SL - 17500 wcb Target 1- 28000 Target 2 - Just Hold and pyramid, as these are one of the best companies in MNC pharma
Previous break out Gap fill Price retesting demand Zone Price reversal from 200 EMA Target 3000+ with Trail SL SL 0.5% BELOW the 200 EMA
3MIndia Break out retest , very good risk to reward entry View negated if weekly close below support